Abbott - Articles and news items

zika virus

FDA approves Abbott’s molecular Zika virus test

Industry news / 3 February 2017 / Niamh Marriott, Digital Editor

The US Food and Drug Administration (FDA) has authorised Abbott’s molecular test to detect Zika virus in whole blood (when collected alongside a patient-matched serum or plasma sample) for emergency use. This is the first molecular test made by a commercial manufacturer authorised to detect Zika in whole blood samples; this is significant since the […]

FDA advisory committee adopts a positive review of Abbott’s Absorb stent

Industry news / 16 March 2016 / Victoria White

Absorb is a first-of-its-kind bioresorbable device for the treatment of coronary artery disease. It dissolves completely after 2 to 3 years…

Abbott to acquire diagnostics company Alere

Industry news / 1 February 2016 / Victoria White

Under the terms of the agreement, Abbott will pay $56 per common share at a total expected equity value of $5.8 billion…

Abbott announces positive results of its naturally dissolving stent

Industry news / 2 September 2015 / Victoria White

ABSORB Japan, a trial comparing the safety and effectiveness of Abbott’s fully dissolving Absorb heart stent to Xience, has produced positive results…

Abbott announces positive results of its naturally dissolving stent from ABSORB Japan study

Abbott announces positive results of its naturally dissolving stent from ABSORB Japan study

Industry news / 1 September 2015 / Nick Jackson

Abbott has announced positive one-year clinical results from ABSORB Japan, a multi-center, randomised trial comparing the safety and effectiveness of Abbott’s fully dissolving AbsorbTM heart stent to XIENCE®…

Data findings highlight common misconceptions about concussion

Industry news / 24 August 2015 / Victoria White

New data from Abbott’s Concussion IQ Survey reveals that many adults lack basic understanding about concussion signs, symptoms, risk and treatment…

Abbott logo

Abbott to present at Cowen and Company 35th Annual Health Care Conference

Industry news / 19 February 2015 / Abbott

Abbott will present at the Cowen and Company 35th Annual Health Care Conference on Tuesday, March 3, 2015…

Abbott logo

Abbott to present at Leerink Global Healthcare Conference

Industry news / 5 February 2015 / Abbott

Abbott will present at the Leerink Global Healthcare Conference on Thursday, Feb. 12, 2015…

US FDA approves two new TECNIS cataracts lenses

US FDA approves two new TECNIS® multifocal intraocular lenses for cataracts

Industry news / 2 February 2015 / Abbott

The US FDA has approved two new TECNIS® multifocal intraocular lenses, allowing people with cataracts to choose the best option for their lifestyle…

Abbott logo

Abbott hosts conference call for fourth-quarter and full-year 2014 earnings

Industry news / 8 January 2015 / Abbott

Abbott will announce its fourth-quarter and full-year 2014 financial results on Thursday, Jan. 29, 2015, before the market opens…

Abbott logo

Abbott commences tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022

Industry news / 16 December 2014 / Abbott

Abbott announced that its wholly-owned subsidiary, Abbott Laboratories (Chile) Holdco (Dos) SpA, a Chilean corporation (“ALH”), has commenced a tender offer (the “U.S. Notes Offer”), in which it is offering to purchase for cash any and all of the outstanding $300 million aggregate principal amount of 5.125% Senior Notes due 2022 (the “Notes”) issued by CFR International SpA…

Abbott logo

Abbott completes acquisition of Veropharm

Industry news / 15 December 2014 / Abbott

Abbott announced that it has acquired control of Veropharm, a leading Russian pharmaceutical manufacturer…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+